125107-15-5 (诺米林酸葡萄糖苷,Nomilinic acid glucoside)

CAS号:
125107-15-5
中文名称:
诺米林酸葡萄糖苷
英文名称:
Nomilinic acid glucoside
分子式:
C34H48O16
分子量:
712.735332489014

诺米林酸葡萄糖苷(125107-15-5)名称与标识符

名称

英文别名:
Nomilinic acid glucoside;(2'S,3S,4aR,7R,8R,8aR)-8-[(1R)-1-acetyloxy-2-carboxyethyl]-3-[(S)-furan-3-yl-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-7-(2-hydroxypropan-2-yl)-3,4a,8-trimethyl-5-oxospi;Limonoic acid, 1-(acetyloxy)-1,4-deepoxy-19-deoxy-O17-beta-D-glucopyranosyl-4-hydroxy-;Nomilinic acid 17-beta-D-glucopyranoside;Nomilinic acid 17-O-beta-D-glucopyranoside;Nomilinic acid 17-O-beta-D-glucoside;Spiro(naphthalene-1(2H),2-oxirane)-5-propanoic acid, beta-(acetyloxy)-3-carboxy-2-((S)-3-furanyl(beta-D-glucopyranosyloxy)methyl)octahydro-6-(1-hydroxy-1-methylethyl)-2,5,8a-trimethyl-8-oxo-, (betaR,1R,2S,3S,4aR,5R,6R,8aR)-;125107-15-5;(2'S,3S,4R,4Ar,7R,8R,8aR)-8-[(1R)-1-acetyloxy-2-carboxyethyl]-3-[(S)-furan-3-yl-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-7-(2-hydroxypropan-2-yl)-3,4a,8-trimethyl-5-oxospiro[2,6,7,8a-tetrahydro-1H-naphthalene-4,3'-oxirane]-2'-carboxylic acid;(2'S,3S,4aR,7R,8R,8aR)-8-[(1R)-1-acetyloxy-2-carboxyethyl]-3-[(S)-furan-3-yl-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-7-(2-hydroxypropan-2-yl)-3,4a,8-trimethyl-5-oxospiro[2,6,7,8a-tetrahydro-1H-naphthalene-4,3'-oxirane]-2'-carboxylic acid;DTXSID00925022;5-[1-(Acetyloxy)-2-carboxyethyl]-2-[(furan-3-yl)(hexopyranosyloxy)methyl]-6-(2-hydroxypropan-2-yl)-2,5,8a-trimethyl-8-oxooctahydro-2H-spiro[naphthalene-1,2'-oxirane]-3'-carboxylic acid;Spiro(naphthalene-1(2H),2'-oxirane)-5-propanoic acid, beta-(acetyloxy)-3'-carboxy-2-((S)-3-furanyl(beta-D-glucopyranosyloxy)methyl)octahydro-6-(1-hydroxy-1-methylethyl)-2,5,8a-trimethyl-8-oxo-, (betaR,1R,2S,3'S,4aR,5R,6R,8aR)-;CCRIS 6988;Nomilinic acid glycoside;AKOS040753304;

标识符

InChIKey:
MUZNNCNJBAPYJF-XMRSMGSPSA-N
Inchi:
1S/C34H48O16/c1-15(36)47-21(12-22(38)39)32(5)18-7-9-31(4,34(27(50-34)28(43)44)33(18,6)20(37)11-19(32)30(2,3)45)26(16-8-10-46-14-16)49-29-25(42)24(41)23(40)17(13-35)48-29/h8,10,14,17-19,21,23-27,29,35,40-42,45H,7,9,11-13H2,1-6H3,(H,38,39)(H,43,44)/t17-,18-,19+,21-,23-,24+,25-,26+,27?,29+,31+,32-,33+,34?/m1/s1
SMILES:
O1C(C(=O)O)C21[C@](C)([C@H](C1=COC=C1)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)CC[C@@H]1[C@@](C)([C@@H](CC(=O)O)OC(C)=O)[C@H](C(C)(C)O)CC([C@@]21C)=O

诺米林酸葡萄糖苷(125107-15-5)物化性质

计算特性

  • 精确分子量 : 712.29423544g/mol
  • 氢键供体数量 : 7
  • 氢键受体数量 : 16
  • 可旋转化学键数量 : 12
  • 同位素质量 : 712.29423544g/mol
  • 重原子数量 : 50
  • 复杂度 : 1350
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 12
  • 不确定原子立构中心数量 : 2
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : -0.6
  • 拓扑分子极性表面积 : 263Ų

诺米林酸葡萄糖苷(125107-15-5)安全信息

诺米林酸葡萄糖苷(125107-15-5)国际标准相关数据

EINECS:

诺米林酸葡萄糖苷(125107-15-5)参考资料

Reaxys RN:
PubChem CID: